abrdn plc Lowers Holdings in Axon Enterprise, Inc. (NASDAQ:AXON)

abrdn plc trimmed its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 26.2% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 259,216 shares of the biotechnology company’s stock after selling 92,159 shares during the quarter. abrdn plc owned about 0.34% of Axon Enterprise worth $155,099,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of AXON. Northwestern Mutual Wealth Management Co. raised its stake in Axon Enterprise by 30.6% during the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 802 shares of the biotechnology company’s stock valued at $236,000 after buying an additional 188 shares during the last quarter. Truist Financial Corp raised its holdings in Axon Enterprise by 53.4% in the 2nd quarter. Truist Financial Corp now owns 6,467 shares of the biotechnology company’s stock worth $1,903,000 after purchasing an additional 2,251 shares during the period. Cetera Investment Advisers lifted its position in Axon Enterprise by 11.8% during the second quarter. Cetera Investment Advisers now owns 23,546 shares of the biotechnology company’s stock valued at $6,928,000 after purchasing an additional 2,479 shares in the last quarter. Sanctuary Advisors LLC bought a new stake in Axon Enterprise during the second quarter valued at about $836,000. Finally, Park Avenue Securities LLC increased its position in Axon Enterprise by 2.3% in the third quarter. Park Avenue Securities LLC now owns 4,426 shares of the biotechnology company’s stock worth $1,769,000 after buying an additional 100 shares in the last quarter. 79.08% of the stock is currently owned by institutional investors.

Insider Activity at Axon Enterprise

In other news, Director Caitlin Elizabeth Kalinowski sold 450 shares of the business’s stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total transaction of $271,831.50. Following the sale, the director now directly owns 6,929 shares of the company’s stock, valued at $4,185,601.03. The trade was a 6.10 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Jeffrey C. Kunins sold 21,834 shares of the firm’s stock in a transaction on Tuesday, November 12th. The stock was sold at an average price of $593.88, for a total value of $12,966,775.92. Following the completion of the transaction, the insider now owns 154,394 shares of the company’s stock, valued at $91,691,508.72. This trade represents a 12.39 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 50,545 shares of company stock worth $30,721,337 over the last three months. 5.70% of the stock is owned by corporate insiders.

Axon Enterprise Trading Up 0.9 %

AXON opened at $658.11 on Tuesday. Axon Enterprise, Inc. has a 52 week low of $252.20 and a 52 week high of $698.67. The company has a market capitalization of $50.18 billion, a P/E ratio of 170.05, a PEG ratio of 6.54 and a beta of 1.05. The stock’s fifty day moving average is $620.41 and its two-hundred day moving average is $486.16. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on AXON shares. Needham & Company LLC boosted their price objective on Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research note on Friday, November 8th. Robert W. Baird upped their price target on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. JMP Securities increased their price objective on shares of Axon Enterprise from $430.00 to $500.00 and gave the stock a “market outperform” rating in a research note on Thursday, October 31st. TD Cowen assumed coverage on shares of Axon Enterprise in a research note on Wednesday, January 8th. They set a “buy” rating and a $700.00 target price on the stock. Finally, Northland Securities increased their price target on Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research note on Monday, November 11th. One research analyst has rated the stock with a hold rating and fourteen have given a buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $524.85.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.